FDA Inspection 1100283 — Watson Pharma Private Ltd.

Watson Pharma Private Ltd. — FEI 3008570026

The FDA completed an inspection of Watson Pharma Private Ltd. on August 23, 2019 in Navi Mumbai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 23, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Navi Mumbai (India)

Additional Details

Clinical BA/BE

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance